Sarcopenia: revised European consensus on definition and diagnosis

Beitrag in einer Fachzeitschrift


Details zur Publikation

Autorinnen und Autoren: Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber C, Topinkova E, Vandewoude M, Visser M, Zamboni M
Zeitschrift: Age and ageing
Jahr der Veröffentlichung: 2019
Band: 48
Heftnummer: 1
Seitenbereich: 16-31
ISSN: 0002-0729


Abstract

Background: in 2010, the European Working Group on Sarcopenia in Older People (EWGSOP) published a sarcopenia definition that aimed to foster advances in identifying and caring for people with sarcopenia. In early 2018, the Working Group met again (EWGSOP2) to update the original definition in order to reflect scientific and clinical evidence that has built over the last decade. This paper presents our updated findings.
Objectives: to increase consistency of research design, clinical diagnoses and ultimately, care for people with sarcopenia.
Recommendations: sarcopenia is a muscle disease (muscle failure) rooted in adverse muscle changes that accrue across a lifetime; sarcopenia is common among adults of older age but can also occur earlier in life. In this updated consensus paper on sarcopenia, EWGSOP2: (1) focuses on low muscle strength as a key characteristic of sarcopenia, uses detection of low muscle quantity and quality to confirm the sarcopenia diagnosis, and identifies poor physical performance as indicative of severe sarcopenia; (2) updates the clinical algorithm that can be used for sarcopenia case-finding, diagnosis and confirmation, and severity determination and (3) provides clear cut-off points for measurements of variables that identify and characterise sarcopenia.
Conclusions: EWGSOP2's updated recommendations aim to increase awareness of sarcopenia and its risk. With these new recommendations, EWGSOP2 calls for healthcare professionals who treat patients at risk for sarcopenia to take actions that will promote early detection and treatment. We also encourage more research in the field of sarcopenia in order to prevent or delay adverse health outcomes that incur a heavy burden for patients and healthcare systems.


FAU-Autorinnen und Autoren / FAU-Herausgeberinnen und Herausgeber

Sieber, Cornel Prof. Dr.
Lehrstuhl für Innere Medizin (Geriatrie)


Einrichtungen weiterer Autorinnen und Autoren

Allgemeines Fakultätskrankenhaus Prag
Catholic University of the Sacred Heart / Università Cattolica del Sacro Cuore
CHU Clermont-Ferrand
Hôpital l'Archet (CHU de Nice)
Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS)
Istanbul University / İstanbul Üniversitesi
Newcastle University
Ruprecht-Karls-Universität Heidelberg
University of Antwerp / Universiteit Antwerpen
University of Liège (ULg) / Université de Liège
University of Southampton
University of Toulouse
University of Verona / Università degli Studi di Verona
Uppsala University
Vrije Universiteit Amsterdam (VU) / University Amsterdam


Zitierweisen

APA:
Cruz-Jentoft, A.J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T.,... Zamboni, M. (2019). Sarcopenia: revised European consensus on definition and diagnosis. Age and ageing, 48(1), 16-31. https://dx.doi.org/10.1093/ageing/afy169

MLA:
Cruz-Jentoft, Alfonso J., et al. "Sarcopenia: revised European consensus on definition and diagnosis." Age and ageing 48.1 (2019): 16-31.

BibTeX: 

Zuletzt aktualisiert 2019-26-03 um 00:08